tanshinone has been researched along with Triple Negative Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, J; Liu, J; Liu, S; Wang, X; Wu, X; Zhang, C | 1 |
| Chen, M; He, Y; Liu, J; Shi, D; Yang, J; Yang, K; Zhang, Z; Zhao, P | 1 |
2 other study(ies) available for tanshinone and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Humans; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53 | 2023 |
Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; GTP-Binding Proteins; Humans; Molecular Docking Simulation; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Triple Negative Breast Neoplasms | 2023 |